Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences, Dynomics Partner for Leukemia, Lymphoma Dx Development

NEW YORK, March 29 (GenomeWeb News) - BD Biosciences has partnered with Dutch diagnostics shop Dynomics to develop tests for leukemia and lymphoma, BD said today.

 

BD now has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion proteins, the company said.

 

William Rhodes, president of cell analysis at BD Biosciences, said that the partnership will give "BD the opportunity to advance technical solutions that can be applied in [its] core markets of ASR and reagent components used in leukemia and lymphoma testing."

 

Financial terms were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.